On multivariate analysis Hb < 9 g/dl remained predictive of mortality after controlling for age, baseline CD4%, WHO clinical stage and weight-for-height z-score (HR 2.95 (95% C.I. 1.04-8.35) p = 0.04).
A retrospective study analyzing young patients (n = 91) with all disease stages from 1983 to 1993, reported that disease stages and weight loss affected survival [ 13].
This permitted the analysis to consider social and economic information such as occupation and educational attainment, essential for PSM, along with health information including WHO staging and weight.
The study question of this paper focuses on changes over 12 months for patients and how the receipt of FA affects health outcomes measured in terms of change in WHO staging and weight of patients receiving TASO care and treatment services.
The whole reaction period could be divided into two stages by this minimum weight point, named the weight-loss stage and the weight-growth stage, which were dominated by the calcination reaction and by the sulfation reaction, respectively.
It has also been found that good performance status (PS), disease stage, age and weight loss are strong prognostic factors in this malignancy.
Similarly, high levels of inflammatory markers and low hemoglobin value, which are usually associated with increased mortality, do not significantly improve the ability to predict survival better than cancer stage, albumin, and weight loss [ 12, 16].
Interviewer-administered questionnaires obtained pubertal staging; height and weight were measured.
Skeletal muscle atrophy is observed in many HD patients despite an adequate diet and food intake [27], significant body weight changes are measurable in early as well as late stage disease [17] and weight loss has recently been shown to track with CAG repeat length [18].
